"Narayana Superspeciality Hospital, Howrah in its ongoing endeavour to make the Kolkata a leading healthcare hub and to address the growing medical needs of people in West Bengal, Bihar, Jharkhand, North-Eastern states and even neighbouring countries such as Bangladesh and Bhutan, Narayana Health offers super specialised tertiary care through Narayana Superspeciality Hospital, just off the Vidyasagar Setu. Narayana Superspeciality Hospital offers comprehensive Cancer Care and Cardiac Sciences facilities, in addition to the various other tertiary care specialities here. Narayana Superspeciality Hospital, Howrah is state-of-the-art super speciality hospital with all modern facilities under one roof."

During the past decade, Narayana Superspeciality Hospital, Howrah conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Narayana Superspeciality Hospital, Howrah" #1 collaborator was "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Narayana Superspeciality Hospital, Howrah" are "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials) and "Lymphoma, Mantle-Cell" (1 trials). Many other conditions were trialed in "Narayana Superspeciality Hospital, Howrah" in a lesser frequency.

Most popular intervention types in "Narayana Superspeciality Hospital, Howrah" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab Intravenous" (1 trials), "Amivantamab Subcutaneous and Co-Formulated with Recombinant Human Hyaluronidase (SC CF)" (1 trials), "Bortezomib" (1 trials), "Ibrutinib" (1 trials) and "Lazertinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Narayana Superspeciality Hospital, Howrah" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Narayana Superspeciality Hospital, Howrah". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Narayana Superspeciality Hospital, Howrah, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Narayana Superspeciality Hospital, Howrah, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".